Solutions by Modality
Antibody
We have extensive experience in preclinical studies of antibody-based therapeutics (e.g., monoclonal antibodies, bispecific antibodies) and systematically evaluate target specificity and immunomodulatory effects.
Key Services
- Antibody-antigen binding characterization: Using methods such as ELISA
- Pharmacodynamic (PD) studies: Evaluation of in vivo and in vitro target specificity
- PK studies: Assessment of in vivo distribution and half-life of antibodies
- Immunogenicity studies: Assessment of immune responses and safety
- Toxicology studies: Conducted using non-human primate models
Highlights
- IND-enabling toxicology studies aligned with global regulatory standards
- Broad expertise in diverse antibody platforms (monoclonal, bispecific, Fc-fusion)